ArticleInternational journal of molecular sciences2021

PDK1 Inhibitor BX795 Improves Cisplatin and Radio-Efficacy in Oral Squamous Cell Carcinoma by Downregulating the PDK1/CD47/Akt-Mediated Glycolysis Signaling Pathway.

Shin Pai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.